HIV Infection
📧 Sign up to get email alerts when something new happens for HIV Infection.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-10-01Clinical Trial Update: A Registry of Tuberculosis Cases in the CPCRA
This entry reports a completed registry study documenting tuberculosis cases within the CPCRA network, sponsored by NIAID, involving HIV inf…
-
CLINICAL_TRIALS trial_result · 2013-09-30Clinical Trial Update: TMC125-TiDP2-C238: An Exploratory Pharmacokinetics, Safety and Anti-HIV Activity Study of Etravirine (ETR) When Given With Boosted Atazanavir (ATV/Rtv) at Two Different Doses and 1 Nucleoside Reverse Transcriptase Inhibitor (NRTI) in Treatment Experienced HIV Patients [Phase 2]
Phase 2 exploratory study assessing pharmacokinetics, safety and anti-HIV activity of etravirine given with boosted atazanavir and one NRTI …
-
EMA guidance · 2013-09-30Consultation on updated guideline on clinical development of medicines for treatment of HIV infection
European Medicines Agency consultation on an updated guideline for the clinical development of medicines for treating HIV infection.
-
CLINICAL_TRIALS trial_result · 2013-09-27Clinical Trial Update: Maternal Determinants of HIV-exposed and HIV-unexposed Fetal Growth, Birth Outcomes and Early Infant Growth
This clinical trial update reports on a completed study examining maternal determinants of fetal growth and birth outcomes in HIV-exposed ve…
-
CLINICAL_TRIALS trial_result · 2013-09-23Clinical Trial Update: Effectiveness of Acyclovir in Suppressing HIV Viral Load in Women Coinfected With HIV and Herpes Simplex Virus Type 2 (HSV-2) [Phase 2]
Phase 2 study investigating whether acyclovir can suppress HIV viral load in women co-infected with HIV and HSV-2. The trial has completed; …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-09-23Clinical Trial Update: Estimating the Incidence of HIV Infection Among Men Who Have Sex With Men in Peru and Ecuador
The trial reports estimates of HIV infection incidence among men who have sex with men in Peru and Ecuador based on completed study data.
-
CLINICAL_TRIALS trial_result · 2013-09-23Clinical Trial Update: Vertical Transmission Study [NA]
A University of KwaZulu-sponsored clinical trial on HIV vertical transmission has completed, according to the posted status update.
-
CLINICAL_TRIALS trial_result · 2013-09-20Clinical Trial Update: Antiviral Therapy in Treating Patients With Slowly Progressing HIV-Related Kaposi's Sarcoma [Phase 2]
A Phase 2 clinical trial is evaluating antiviral therapy for slowly progressing HIV-related Kaposi's sarcoma.
-
CLINICAL_TRIALS trial_result · 2013-09-19Clinical Trial Update: Comparison of Treatment Simplification by LPV/r vs Current Treatment Continuation in HIV-Infected Patients [Phase 3]
Phase 3 clinical trial comparing simplification with lopinavir/ritonavir (LPV/r) versus continuing current HIV regimens in HIV-infected pati…
-
CLINICAL_TRIALS trial_result · 2013-09-18Clinical Trial Update: Vitamin D Dose Finding Study [Phase 2]
Phase 2 dose-finding trial investigating Vitamin D (cholecalciferol) in people with HIV infection and AIDS. The study has completed and resu…
-
CLINICAL_TRIALS trial_result · 2013-09-17Clinical Trial Update: A Pharmacokinetic Study to Evaluate the Effect of Antacids on Raltegravir (MK-0518) in HIV-Infected Participants (MK-0518-247) [Phase 1]
A Phase 1 pharmacokinetic study evaluating the effect of antacids on raltegravir exposure in HIV-infected participants, with results posted …
-
CLINICAL_TRIALS trial_result · 2013-09-17Clinical Trial Update: Motivating HIV+ Women: Risk Reduction and ART Adherence [NA]
This entry notes the completion of a clinical trial at Emory University evaluating risk reduction strategies and adherence to antiretroviral…
-
FDA approval · 2013-09-13FDA Approved: ABACAVIR — Original Application (Camber Pharmaceuticals, Inc.)
FDA approves Camber Pharmaceuticals' original application for abacavir, a generic antiretroviral for HIV-1 infection.
-
CLINICAL_TRIALS trial_result · 2013-09-12Clinical Trial Update: Prevention of Lipoatrophy in Patients Treated With Lopinavir/Ritonavir in Monotherapy Versus ZDV + 3TC + ABC [Phase 4]
Phase 4 trial comparing lopinavir/ritonavir monotherapy to zidovudine/lamivudine/abacavir triple therapy for preventing lipoatrophy in HIV-i…
-
CLINICAL_TRIALS trial_result · 2013-09-12Clinical Trial Update: A Feasibility Study of Co-administering Combination Antiretroviral Therapy (cART) and R-EPOCH Chemotherapy for the Management of ARL [Phase 2]
Phase 2 feasibility trial evaluating co-administration of combination antiretroviral therapy (cART) with R-EPOCH chemotherapy for AIDS-relat…
-
CLINICAL_TRIALS trial_result · 2013-09-12Clinical Trial Update: Exercise and Pioglitazone for HIV-Metabolic Syndromes [NA]
A completed clinical trial from NIDDK examining the combination of exercise and pioglitazone for HIV-associated metabolic syndromes, with re…
-
CLINICAL_TRIALS trial_result · 2013-09-12Clinical Trial Update: Long-term Atazanavir Experience in a High HIV Caseload Primary Care Practice in Sydney, Australia
This document reports the long-term use and observational experience of atazanavir in a high HIV caseload primary care clinic in Sydney, bas…
-
FDA approval · 2013-09-11FDA Approved: ZIAGEN — Supplemental Application (ViiV Healthcare Company)
FDA approves a supplemental application for Ziagen (abacavir sulfate) from ViiV Healthcare Company.
-
CLINICAL_TRIALS trial_result · 2013-09-10Clinical Trial Update: Maraviroc Immune Recovery Study [Phase 4]
This entry notes that the Phase 4 clinical trial evaluating Maraviroc (Selzentry) for HIV infection has completed.
-
CLINICAL_TRIALS trial_result · 2013-09-09Clinical Trial Update: Safety and Immune Response Assessment Study of Killed-whole HIV-1 Vaccine (SAV001-H) in Chronic HIV-1 Infected Patients [Phase 1]
Phase 1 trial update reporting safety and immune response data for the killed-whole HIV-1 vaccine SAV001-H in adults with chronic HIV infect…
-
CLINICAL_TRIALS trial_result · 2013-09-06Clinical Trial Update: A Study to Evaluate the Use of a Protease Inhibitor and of Interleukin-2 (IL-2) in the Treatment of Early HIV Infection [Phase 3]
This clinical trial update reports on a Phase 3 study evaluating a protease inhibitor and interleukin-2 (IL-2) for the treatment of early HI…
-
CLINICAL_TRIALS trial_result · 2013-09-06Clinical Trial Update: Safety of and Immune Response to Prime/Boost Vaccine Regimens in Healthy, HIV-1 Uninfected, Ad5 Seronegative Adults [Phase 1]
Phase 1 trial evaluating safety and immunogenicity of prime/boost HIV vaccine regimens in healthy HIV-1 uninfected adults who are Ad5 serone…
-
CLINICAL_TRIALS trial_result · 2013-09-05Clinical Trial Update: Study on Long Term Outcomes of Atazanavir in Antiretroviral-naïve Human Immunodeficiency Virus (HIV) Patients in Real Life Setting
A completed study evaluating long-term outcomes of initiating atazanavir in antiretroviral-naïve HIV patients in real-world clinical setting…
-
CLINICAL_TRIALS trial_result · 2013-09-05Clinical Trial Update: Neighborhoods, Networks, Depression, and HIV Risk [Phase 2]
Phase 2 clinical trial examining how neighborhoods and social networks relate to depression and HIV risk has completed, sponsored by Johns H…
-
CLINICAL_TRIALS trial_result · 2013-09-05Clinical Trial Update: Evaluation of an Intervention on Adherence to Highly Active Antiretroviral Therapy (HAART) in HIV Infected Adults [NA]
A terminated clinical trial evaluating an intervention to improve adherence to HAART in HIV-infected adults.